Home
Edward J. Dulac III, CFO: Fate Therapeutics FATE Sell · Filed 24/01/03
Trade details
- Type
- Insider sale
- Amount
- $18,966.12
- Shares · price
- 5,182 sh · $3.66 a share
- Held after
- 112,803 sh
- Person
- Edward J. Dulac IIICFO
- Trade date
- 24/01/02
- Filed
- 24/01/03
- Days to filing
- 1 days
Sold 4.4% of holdings
- Share of holding sold
- 4.4%
Fate Therapeutics trades, last 26 weeks
What else happened in Fate Therapeutics around then
Filed or reported within 30 days of the trade day · 23/12/03~24/02/01Edward J. Dulac III's recent trades
- Edward J. Dulac III
Planned sale10b5-1 planIntellia Therapeutics
Planned sale10b5-1 planIntellia Therapeutics
NTLA
$80.6K
4,677 sh
$80.6K
Filed 07/02
Traded 07/02
- Edward J. Dulac III
SellIntellia Therapeutics
SellIntellia Therapeutics
NTLA
$58.8K
6,379 sh
$58.8K
Filed 01/07
Traded 01/05
- Edward J. Dulac III
SellIntellia Therapeutics
SellIntellia Therapeutics
NTLA
$104.6K
7,462 sh
$104.6K
Filed 25/07/25
Traded 25/07/23
- Edward J. Dulac III
Sell10b5-1 planFate Therapeutics
Sell10b5-1 planFate Therapeutics
FATE
$19K
2,447 sh
$19K
Filed 24/03/05
Traded 24/03/04
- Edward J. Dulac III
Sell10b5-1 planFate Therapeutics
Sell10b5-1 planFate Therapeutics
FATE
$9,245
1,849 sh
$9,245
Filed 24/01/30
Traded 24/01/29
